In recent years, studies have found that E2F1, a downstream effector of caveolin-1 (Cav-1), participates in tumor cell metabolic reprogramming. E2F1 modulates mitochondrial fusion and mitophagy. Bioinformatic analysis has identified the E2F1-MFN2 axis as a regulator of mitophagy. Our data establish a new novel paradigm for regulation of the tumor cell metabolic reprogramming pathway by Cav-1 that is operationally linked and mutually dependent on the transcriptional activation of E2F1 and induces mitophagy with BNIP3 in cancerassociated fibroblasts (CAFs).As a founding member of E2F family of transcription factors, E2F transcription factor 1 (E2F1) participates in regulating cell-cycle progression, cell differentiation, DNA repair, and apoptosis. 1 In recent years, studies have found that E2F1 participates in tumor cell metabolic reprogramming in addition to regulating the cell cycle, and plays an important role in the occurrence and development of tumors. 2 Depending on the cellular context and environmental conditions, it can function as either an oncogene or a tumor suppressor gene.Bucha et al. found 3 that E2F1 modulated mitochondrial fusion and mitophagy, probably through regulation of MFN2. Bioinformatic analysis identified the E2F1-MFN2 axis as a regulator of mitochondrial morphology and mitophagy, which is the most direct evidence to show the relationship between E2F1 and mitophagy. Previous research has showed that BCL2 interacting protein 3 (BNIP3) is a direct transcriptional target of E2F1 that is necessary and sufficient for E2F1-induced mitophagy. 4 BNIP3 at the outer mitochondrial membrane interacts with processed LC3 at phagophore membranes to promote sequestration of mitochondria within the autophagosome for degradation. 5 Yurkova et al. 4 provided the first direct evidence that activation of the intrinsic mitochondrial death pathway by E2F1 is mutually dependent on, and obligatorily linked to, the transcriptional activation of BNIP3.In lung cancer, the normal fibroblasts (NFs) are activated as cancer-associated fibroblasts (CAFs), and act in the realms of the tumor microenvironment (TME) with consequences for tumor growth, formation of stem cell niches, immunosuppression, metastasis and chemoresistance. 6,7 A number of studies have suggested that CAFs are key in cancer progression. Caveolin-1 (Cav-1) is found predominately in terminally differentiated cells, such as adipocytes, endothelia and smooth muscle cells, as well as type I pneumocytes. 8,9 As the first member of the Cav family, Cav-1, a 22 kDa protein of 178 amino acids, has been the most sufficiently investigated in a number of biochemical studies. The downregulation of Cav-1 is a major characteristic of CAFs and existing studies have indicated that CAFs have the ability to prevent cancer cell apoptosis, enhance the proliferation of cancer cells and stimulate tumor angiogenesis. 10 It has also been reported that the downregulation of Cav-1 is one of the mechanisms that mediates the 1369 This is an open access article under the terms of th...